Sarissa Capital Offshore Master Fund LP
10% Owner

Sarissa Capital Offshore Master Fund LP insider trades: Iterum Therapeutics (ITRM) stock buys and sales

10% Owner, Iterum Therapeutics Last trade Feb 12, 2021 7 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
4
Open-market trades
since 2016
3
Companies
last trade 2021

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Sarissa Capital Offshore Master Fund LP reports to the SEC

Open-market buys and sales

4 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 12, 2021ITRM↓ Sell$50.0M
Aug 31, 2017APRI↑ Buy$10K
Mar 3, 2016APRI↑ Buy$5.9M
Jan 12, 2016APRI↑ Buy$1.2M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ITRM insiders

Open-market trades in the last 12 months

About Sarissa Capital Offshore Master Fund LP's insider trades

Sarissa Capital Offshore Master Fund LP is a 10% owner of Iterum Therapeutics (ITRM). Since Jan 12, 2016, it has reported 3 open-market purchases worth $7.0M and 1 sale worth $50.0M on SEC Form 4. There have been no open-market trades in the last 12 months.

Its filings also include other transactions (6 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ITRM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.